<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107">
 <label>107.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ghisoli</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Barve</surname>
    <given-names>M</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Mennel</surname>
    <given-names>R</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Three-year follow up of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy (Vigil) in metastatic advanced Ewing's sarcoma</article-title>. 
  <source>Mol. Ther.</source>
  <volume>24</volume>(
  <issue>8</issue>), 
  <fpage>1478</fpage>â€“
  <lpage>1483</lpage> (
  <year>2016</year>).
  <pub-id pub-id-type="pmid">27109631</pub-id>
 </mixed-citation>
</ref>
